Nov 19, 2024
To seek long term capital appreciation by investing at least 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sector in India.
| Returns Type | 1 Month (%) | 6 Months (%) | 1 Year (%) | 3 Years (%) | 5 Years (%) | Since Inception (%) |
|---|---|---|---|---|
| Scheme - Tata India Pharma & Healthcare Fund (IDCW) RI | -5.29 | 15.76 | 39.29 | 19.26 |
| Benchmark - Nifty Pharma TRI | -6.78 | 14.41 | 38.69 | 18.23 |
| Category Average - BEST EQUITY PERFORMERS | -5.9 | 6.66 | 30.15 | 16.56 |
| Category Rank | 7/7 | 7/7 | 6/7 | 7/7 |
| Fund Name | Nav () | Chg (%) | 1Y Return(%) | 3Y Return(%) | 5Y Return(%) | AUM ( in Crs) | Exp. Ratio (%) | Min.Invst() | Action |
|---|---|---|---|---|---|---|---|---|---|
| Nippon India Taiwan Equity Fund (IDCW) | 11.4604 | 2.98 | 25.58 | 0.00 | 0.00 | 364.14 | 2.43 | 500.00 | invest |
| Nippon India Taiwan Equity Fund (G) | 11.4604 | 2.98 | 25.58 | 0.00 | 0.00 | 364.14 | 2.43 | 500.00 | invest |
| SBI Automotive Opportunities Fund - Regular (G) | 9.6655 | 1.62 | 0.00 | 0.00 | 0.00 | 6,003.23 | 1.79 | 5,000.00 | invest |
| SBI Automotive Opportunities Fund - Regular (IDCW) | 9.6656 | 1.62 | 0.00 | 0.00 | 0.00 | 6,003.23 | 1.79 | 5,000.00 | invest |
| SBI Energy Opportunities Fund - Regular (G) | 10.1076 | -0.49 | 0.00 | 0.00 | 0.00 | 10,889.77 | 1.72 | 5,000.00 | invest |
| Company Name | As on Date | Invested Amt (Cr) | % Portfolio Weight | Change (%) (Invested Amt.) |
4 Months Trends |
|---|---|---|---|---|---|
| Equity-Sun Pharma.Inds. | Oct 31, 2024 | 148.71 | 12.31 | -4.04 |
|
| Equity-Aurobindo Pharma | Oct 31, 2024 | 103.48 | 8.57 | -4.40 |
|
| Equity-Lupin | Oct 31, 2024 | 89.72 | 7.43 | -0.19 |
|
| Equity-Dr Reddy`s Labs | Oct 31, 2024 | 78.31 | 6.48 | -5.64 |
|
| Equity-Cipla | Oct 31, 2024 | 76.04 | 6.29 | -6.19 |
|
| Net CA & Others-Net CA & Others | Oct 31, 2024 | 63.10 | 5.23 | -12.49 |
|
| Equity-Divi`s Lab. | Oct 31, 2024 | 61.82 | 5.12 | 8.20 |
|
| Equity-Fortis Health. | Oct 31, 2024 | 53.42 | 4.42 | 1.56 |
|
| Equity-Zydus Lifesci. | Oct 31, 2024 | 47.19 | 3.91 | -6.30 |
|
| Equity-Alkem Lab | Oct 31, 2024 | 43.49 | 3.60 | -4.52 |
|
Tata Mutual Fund has launched a new thematic fund, the Tata India Innovatio...
Tata Mutual Fund has announced 06 November 2024 as the record date for decl...
Tata Mutual Fund has announced the launch of the Tata Nifty Capital Markets...
Tata Mutual Fund has announced 10 October 2024 as the record date for decla...
Tata Mutual Fund has announced 03 October 2024 as the record date for decla...
Tata Mutual Fund has announced change in exit load structure under followin...
| AMC Name | : | Tata Mutual Fund |
| Fund Name | : | Tata India Pharma & Healthcare Fund (IDCW) RI |
| Contact Persone | : | Meeta Shetty |
| Registered Address | : | 1903, B-Wing, Parinee Crescenzo,G-Block, Bandra Kurla Complex,Bandra East Mumbai - 400051 |
| Telephone No | : | 022 62827777 |
| Fax No. | : | 022 2261 3782. |
| : | service:tataamc.com | |
| Website | : | www.tatamutualfund.com |
Top Mutual Funds
